Glen Tullman is the executive chairman and founder of Livongo Health (NASDAQ: LVGO), the consumer first digital health pioneer committed to empowering people with chronic conditions to live better and healthier lives. He is dedicated to finding a cure for diabetes and other chronic conditions—and to keeping people healthy until these cures are found.
A visionary leader and entrepreneur, he previously ran two public companies that changed the way healthcare is delivered. Prior to Livongo, Tullman served as chief executive officer of Allscripts, which was, during his tenure, the leading provider of electronic health records, practice management and electronic prescribing systems. He took Allscripts public. Prior to Allscripts, he was chief executive officer of Enterprise Systems, which he also took public and then sold to McKesson/HBOC. He is the author of On Our Terms: Empowering the New Health Consumer, in which he proposes new solutions to address the chronic-condition epidemic facing our country.
A strong proponent of philanthropy, Glen was honored in 2019 with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy and efficiency of our healthcare system. He also serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation and as a Board Member of the American Diabetes Association. Glen has three amazing children that inspire him every day.